NYSE · ASH

Ashland Inc.

$66.38 -$0.02 (-0.03%) 1D After hours

Key Metrics

$3.04B
Market cap
P/E · TTM
$1.81B
Revenue · TTM
−$707.00M
Net income
EPS · TTM $-15,369,565.22
Dividend yield 2.5%
Free cash flow $245.00M
Beta · 1Y 1.11
EBITDA · TTM −$415.00M
Gross margin 30.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 9
    The stock moved +8.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 9
  • Apr 29
    The stock moved -13.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 29

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.04B
Enterprise value$4.07B
Shares outstanding45.8M
52-wk range$46.30 – $69.66
Avg volume · 20D525.0K
Net cash −$1.03B
Book value / share$40,565,217.39
IndustryWholesale-Chemicals & Allied Products
ExchangeNYSE
About Ashland Inc.
IPO dateMay 8, 1950
Employees2900

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.68
P/FCF12.41
EV/EBITDA
EV/Sales2.25
Graham №

Profitability

Gross 30.0%
Operating -35.1%
Net -39.1%
FCF 13.6%
ROE / ROIC -29.9% · -23.6%

Financial Health

Current ratio3.06
Quick ratio1.78
Debt / equity0.74
Debt / EBITDA -3.31
Net cash −$1.03B
Working capital$814.00M

Cash Flow · TTM

Operating CF $330.00M
Capex −$85.00M
Free cash flow $245.00M
Buybacks $0
Dividends paid $76.00M
Shareholder yield 2.5%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings